Irani Thevarajan

Dr. Irani Thevarajan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
JHJennifer R. Habel
Jennifer R. Habel
BCBrendon Y. Chua
Brendon Y. Chua
LKLukasz Kedzierski
Lukasz Kedzierski
KSKevin J. Selva
Kevin J. Selva
TDTimon Damelang
Timon Damelang
KKKatherine Kedzierska
Katherine Kedzierska
Pregnancy poses a greater risk for severe COVID-19; however, underlying immunological changes associated with SARS-CoV-2 during pregnancy are poorly understood. We defined immune responses to SARS-CoV-2 in unvaccinated pregnant and nonpregnant women with acute and convalescent COVID-19, quantifying 217 immunological parameters. Humoral responses to SARS-CoV-2 were similar in pregnant and nonpregnant women, although our systems serology approach revealed distinct antibody and FcγR profiles between pregnant and nonpregnant women. Cellular analyses demonstrated marked differences in NK cell and unconventional T cell activation dynamics in pregnant women. Healthy pregnant women displayed preactivated NK cells and γδ T cells when compared with healthy nonpregnant women, which remained unchanged during acute and convalescent COVID-19. Conversely, nonpregnant women had prototypical activation of NK and γδ T cells. Activation of CD4 + and CD8 + T cells and T follicular helper cells was similar in SARS-CoV-2–infected pregnant and nonpregnant women, while antibody-secreting B cells were increased in pregnant women during acute COVID-19. Elevated levels of IL-8, IL-10, and IL-18 were found in pregnant women in their healthy state, and these cytokine levels remained elevated during acute and convalescent COVID-19. Collectively, we demonstrate perturbations in NK cell and γδ T cell activation in unvaccinated pregnant women with COVID-19, which may impact disease progression and severity during pregnancy.

1 May 2021 in Infection, Disease & Health
Verified
Journal Article
Closed access
JFJesse J. Fryk
Jesse J. Fryk
STSteven Tong
Steven Tong
CMCaroline Marshall
Caroline Marshall
ARArjun Rajkhowa
Arjun Rajkhowa
KBKirsty Buising
Kirsty Buising
ITIrani Thevarajan
Irani Thevarajan

Verified
Journal Article
Open access
PDF file
SRStacey Rowe
Stacey Rowe
ITIrani Thevarajan
Irani Thevarajan
JRJack Richards
Jack Richards
KGKatherine Gibney
Katherine Gibney
CSCameron P. Simmons
Cameron P. Simmons
Dengue notifications have increased dramatically over the past seven years in Victoria, Australia—a trend which has been seen nationally and reflects increased cases internationally. We reviewed the epidemiology of dengue among Victorian travellers, changes in diagnostic methods and describe the burden placed on local health systems resulting from this disease of public health importance. Cases of dengue notified to the Department of Health and Human Services in Victoria, Australia, between 1 January 2010 and 31 December 2016 were included in this review. Demographic, clinical, diagnostic methods, and risk factor data were examined using descriptive epidemiological analyses. Cases of dengue increased on average by 22% per year, with a total of 2187 cases (5.5 cases/100,000 population) notified over the 7-year reporting period. The most frequently reported country of acquisition was Indonesia (45%) followed by Thailand (14%). The use of multiple diagnostic methods, including the non-structural protein 1 antigen (NS1Ag) detection test, increased over time. The median time between onset of illness and diagnosis diminished from 9 days (IQR: 2–15) in 2010 to 4 days (IQR: 2–7) in 2016. Proportionally more cases were discharged directly from emergency departments in recent years (10% in 2010 to 28% in 2016, p < 0.001).The increasing incidence of dengue in Australia is reflective of its growing prominence as a travel medicine problem in western countries. For travellers with non-severe dengue, the improved timeliness of dengue diagnostics allows for consideration of best practice ambulatory management approaches as used in endemic areas.

Verified
Journal Article
Open access
PDF file
YWYa Wang
Ya Wang
Klaus SchughartKlaus Schughart
Klaus Schughart
TPTiana Maria Pelaia
Tiana Maria Pelaia
TCTracy Chew
Tracy Chew
KKKaran Kim
Karan Kim
MSMaryam Shojaei
Maryam Shojaei
Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). Mitochondrion, the very organelle that controls cellular metabolism, holds the key to understanding disease progression at the cellular level. Our current study aimed to understand how cellular metabolism contributes to COVID-19 outcomes. Metacore pathway enrichment analyses on differentially expressed genes (encoded by both mitochondrial and nuclear deoxyribonucleic acid (DNA)) involved in cellular metabolism, regulation of mitochondrial respiration and organization, and apoptosis, was performed on RNA sequencing (RNASeq) data from blood samples collected from healthy controls and patients with mild/moderate or severe COVID-19. Genes from the enriched pathways were analyzed by network analysis to uncover interactions among them and up- or downstream genes within each pathway. Compared to the mild/moderate COVID-19, the upregulation of a myriad of growth factor and cell cycle signaling pathways, with concomitant downregulation of interferon signaling pathways, were observed in the severe group. Matrix metallopeptidase 9 (MMP9) was found in five of the top 10 upregulated pathways, indicating its potential as therapeutic target against COVID-19. In summary, our data demonstrates aberrant activation of endocrine signaling in severe COVID-19, and its implication in immune and metabolic dysfunction.

23 February 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ITIrani Thevarajan
Irani Thevarajan
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
MKMarios Koutsakos
Marios Koutsakos
JDJulian Druce
Julian Druce
LCLeon Caly
Leon Caly
KKKatherine Kedzierska
Katherine Kedzierska
We report the kinetics of the immune response in relation to clinical and virological features of a patient with mild-to-moderate coronavirus disease-19 (COVID-19) requiring hospitalisation. Increased antibody-secreting cells, follicular T-helper cells, activated CD4 + and CD8 + T-cells and IgM/IgG SARS-CoV-2-binding antibodies were detected in blood, prior to symptomatic recovery. These immunological changes persisted for at least 7 days following full resolution of symptoms, indicating substantial anti-viral immunity in this non-severe COVID-19.

24 December 2019 in Medical Journal of Australia
Verified
Journal Article
Closed access
ITIrani Thevarajan
Irani Thevarajan
JTJoseph Torresi
Joseph Torresi
CSCameron Simmons
Cameron Simmons